Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4/5
Dong E E Jiaoco Ltd A (000423 CH)
Watchlist
36
Analysis
Health Care
•
China
Dong-E-E-Jiao Co., Ltd. primarily manufactures and sells traditional Chinese medicine, health care products, health foods, and bio-medicine. The company also engages in gelatin products manufacturing.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Guangzhou Baiyunshan Pharmaceutical Holdings
•
23 Dec 2021 01:10
Guangzhou Baiyunshan Pharmaceutical Holdings (874.HK) - Conservative About the Outlook
This insight analyzed Baiyunshan’s 2021Q3 performance, the core business segments, the comparison with peers, the concerns on business transition,...
Xinyao (Criss) Wang
Follow
561 Views
Share
bullish
•
Beijing Tong Ren Tang Chinese Medicine
•
04 Jan 2021 14:25
Beijing Tong Ren Tang Chinese Medicine: A Turnaround Worth A Look
Beijing Tong Ren Tang Chinese Medicine can be a rare turnaround case in our opinion, thanks to its wide moat and compounding capability.
Steven Chen
Follow
623 Views
Share
bullish
•
Kweichow Moutai
•
17 Jun 2019 07:26
Shanghai/Shenzhen Connect Ideas: Moutai Inflows Were Back, Tsingtao Too (2019-06-14)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
667 Views
Share
bearish
•
China Resources Pharmaceutical
•
01 May 2018 15:52
"Donkey Skin" Rhymes With "Shark Fin" Update
Recall that E-Jiao, a Traditional Chinese Medicine made from donkey skin, is one of China Resources Pharmaceutical Group (3320 HK) 's leading...
Kemp Dolliver, CFA
424 Views
Share
bearish
•
China Resources Pharmaceutical
•
05 Dec 2016 18:23
"Donkey Skin" Rhymes With "Shark Fin"
China Resources Pharmaceutical (3320 HK) is an integrated manufacturer, distributor, and retailer of pharmaceutical products. The company's leading...
Kemp Dolliver, CFA
477 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x